Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease
Clicks: 316
ID: 121067
1987
Thirty children 1 to 33 months of age were enrolled in a study of aerosolized ribavirin therapy for respiratory syncytial virus lower respiratory tract illness. Twenty patients received ribavirin and 10 received placebo. There were no significant differences between the groups in chronologic or gest …
| Reference Key |
wj1987theaerosolized
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Rodriguez WJ;Kim HW;Brandt CD;Fink RJ;Getson PR;Arrobio J;Murphy TM;McCarthy V;Parrott RH;; |
| Journal | the pediatric infectious disease journal |
| Year | 1987 |
| DOI | DOI not found |
| URL | |
| Keywords |
Administration
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
clinical trials as topic
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
Child
Infant
preschool
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Random Allocation
inhalation
respirovirus infections / physiopathology
respiratory syncytial viruses / isolation & purification
controlled clinical trial
ribavirin / administration & dosage
ribavirin / therapeutic use*
respirovirus infections / drug therapy*
ribonucleosides / therapeutic use*
h w kim
r h parrott
w j rodriguez
pmid:3550679
doi:10.1097/00006454-198702000-00004
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.